Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Change in Cash (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Change in Cash came in at -$40.3 million in Q1 2026, down 38.01% YoY from -$65.1 million in Q1 2025, and down 129.26% on a QoQ basis from $137.8 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Change in Cash (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Change in Cash data on file, last reported at -$40.3 million in Q1 2026.

  • Quarterly Change in Cash fell 38.01% year-over-year to -$40.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.7 million (up 128.65% YoY) and the FY2025 annual result came in at $41.8 million, up 135.54% from the prior year.
  • Change in Cash retreated to -$40.3 million in Q1 2026, from $137.8 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $137.8 million in Q4 2025 to a low of -$499.0 million in Q2 2022.
  • A 5-year average of -$33.1 million and a median of -$29.8 million in 2024 frame the typical range for Change in Cash.
  • Annual changes were most pronounced in 2022 — Change in Cash sank 1160.48% — and 2025, when it jumped 562.65%.
  • Tracing KOD's Change in Cash over 5 years: stood at $12.0 million in 2022, then sank by 600.51% to -$60.2 million in 2023, then surged by 50.48% to -$29.8 million in 2024, then jumped by 562.65% to $137.8 million in 2025, then tumbled by 129.26% to -$40.3 million in 2026.
  • The last three Change in Cash figures came in at -$40.3 million (Q1 2026), $137.8 million (Q4 2025), and -$32.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - -43.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.63 Mn
Mar 31, 2026 -40.33 Mn
Dec 31, 2025 137.82 Mn
Sep 30, 2025 -32.13 Mn
Jun 30, 2025 -34.69 Mn
Mar 31, 2025 -29.22 Mn
Dec 31, 2024 -29.79 Mn
Sep 30, 2024 -21.36 Mn
Jun 30, 2024 -26.69 Mn
Mar 31, 2024 -39.73 Mn
Dec 31, 2023 -60.16 Mn
Sep 30, 2023 -33.00 Mn
Jun 30, 2023 62.06 Mn
Mar 31, 2023 126.18 Mn
Dec 31, 2022 12.02 Mn
Sep 30, 2022 5.72 Mn
Jun 30, 2022 -499.04 Mn
Mar 31, 2022 -59.78 Mn
Dec 31, 2021 -67.74 Mn
Sep 30, 2021 -81.62 Mn